Literature DB >> 335509

Mandelonitrile beta-glucuronide: synthesis and characterization.

C Fenselau, S Pallante, R P Batzinger, W R Benson, R P Barron, E B Sheinin, M Maienthal.   

Abstract

Mandelonitrile beta-glucuronide, the compound patented as Laetrile, has been synthesized from rabbit liver uridine diphosphate-glucuronosyl transferase immobilized on beaded sepharose, has been analyzed by thin-layer chromatography, nuclear magnetic resonance, and gas chromatography-mass spectrometry, and has been tested for cytotoxicity and mutagenic activity with Salmonella typhimurium strains TA 98 and TA 100. Several commercial laetrile preparations contained no glucuronide; they contained amygdalin and neoamygdalin instead. Mandelonitrile, mandelonitrile glucuronide, and a mixture of amygdalin and neoamygdalin were each found to be mutagenic.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 335509     DOI: 10.1126/science.335509

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

Review 1.  Toxic phytochemicals and their potential risks for human cancer.

Authors:  Ann M Bode; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2014-10-27

2.  Pharmacology of amygdalin (laetrile) in cancer patients.

Authors:  M M Ames; T P Moyer; J S Kovach; C G Moertel; J Rubin
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  The pharmacokinetics of amygdalin.

Authors:  A G Rauws; M Olling; A Timmerman
Journal:  Arch Toxicol       Date:  1982-03       Impact factor: 5.153

Review 4.  Laetrile for cancer: a systematic review of the clinical evidence.

Authors:  Stefania Milazzo; Stephane Lejeune; Edzard Ernst
Journal:  Support Care Cancer       Date:  2006-11-15       Impact factor: 3.359

Review 5.  Laetrile treatment for cancer.

Authors:  Stefania Milazzo; Markus Horneber
Journal:  Cochrane Database Syst Rev       Date:  2015-04-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.